Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL770250 | 0.84 | — | — | |
| Formamide SCHEMBL3330461 | 0.74 | — | — | |
| Formamide SCHEMBL3632800 | 0.72 | — | — | |
| Trimethylammonium SCHEMBL27422984 | 0.69 | — | — | |
| SCHEMBL10928502 | 0.67 | — | — | |
| SCHEMBL28224637 | 0.67 | — | — | |
| SCHEMBL7058496 | 0.67 | — | — | |
| Formamide SCHEMBL20721941 | 0.66 | — | — | |
| Trimethylammonium SCHEMBL27382477 | 0.66 | — | — | |
| Tert-Butanol SCHEMBL9717203 | 0.65 | TSHR (0.64) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10100002-B2 | Method for separating N,N,N'-trimethylbisaminoethylether and/or N,N-dimethylbisaminoethylether from a mixture | HUNTSMAN INTERNATIONAL LLC (US) | 2018-10-16 | — | — | US | disclosed |
| EP-3057937-A1 | METHOD FOR SEPARATING N,N,N'-TRIMETHYLBISAMINOETHYLETHER AND/OR N,N-DIMETHYLBISAMINOETHYLETHER FROM A MIXTURE | Huntsman Corporation Hungary ZRt. (HU) | 2016-08-24 | — | — | EP | disclosed |
| US-20160237024-A1 | Method for Separating N,N,N'-Trimethylbisaminoethylether and/or N,N-Dimethylbisaminoethylether from a Mixture | Huntsman Corporation Hungary ZRt (HU) | 2016-08-18 | — | — | US | disclosed |
| WO-2015055406-A1 | METHOD FOR SEPARATING N,N,N'-TRIMETHYLBISAMINOETHYLETHER AND/OR N,N-DIMETHYLBISAMINOETHYLETHER FROM A MIXTURE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2015-04-23 | — | — | WO | disclosed |
| EP-2862851-A1 | Method for separating N,N,N'-trimethylbisaminoethylether and/or N,N-dimethylbisaminoethylether from a mixture | Huntsman Corporation Hungary ZRt. (HU) | 2015-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237024-A1 | Method for Separating N,N,N'-Trimethylbisaminoethylether and/or N,N-Dimethylbisaminoethylether from a Mixture | NAAA, NAT1, NUCB2 | TSHR 2526/4885 |
| US-10100002-B2 | Method for separating N,N,N'-trimethylbisaminoethylether and/or N,N-dimethylbisaminoethylether from a mixture | NAAA, NAT1, NUCB2 | TSHR 2526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.